Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | PRCP | P42785 | 1/20 | 0.45 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25848870 | 0.86 | SIGMAR1 (0.55) | SIGMAR1LTA4HMEN1TP53CYP1A2 | |
| SCHEMBL21965867 | 0.80 | DRD2 (0.46) | MEN1KMT2ASLC18A3DRD2PRCP | |
| SCHEMBL18673331 | 0.79 | LTA4H (0.57) | SIGMAR1LTA4HMEN1CYP1A2CYP3A4 | |
| SCHEMBL22537840 | 0.78 | DRD2 (0.51) | SIGMAR1MEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL15186974 | 0.77 | ACHE (0.64) | SIGMAR1LTA4HMEN1KMT2AHRH3 | |
| SCHEMBL24240460 | 0.77 | MEN1 (0.55) | BCHEMEN1KMT2ADRD2 | |
| SCHEMBL12128622 | 0.76 | MEN1 (0.60) | SIGMAR1LTA4HMEN1CYP1A2CYP3A4 | |
| SCHEMBL13252503 | 0.75 | LTA4H (0.58) | SIGMAR1LTA4HHRH3 | |
| SCHEMBL19557301 | 0.75 | LTA4H (0.75) | SIGMAR1LTA4HMEN1TP53CYP1A2 | |
| SCHEMBL26981197 | 0.75 | LTA4H (0.75) | SIGMAR1LTA4HMEN1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793990-B1 | ANTIBACTERIAL COMPOUNDS | INFEX THERAPEUTICS LTD (GB) | 2023-07-19 | — | — | EP | disclosed |
| US-20230060011-A1 | ANTIBACTERIAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2023-02-23 | — | — | US | disclosed |
| US-20210230115-A1 | Antibacterial Compounds | Infex Therapeutics Limited (GB) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230060011-A1 | ANTIBACTERIAL COMPOUNDS | GAA, MGAM, NQO1 | SIGMAR1 2219/4885BCHE 170/4885LTA4H 268/4885 |
| US-20210230115-A1 | Antibacterial Compounds | GAA, MGAM, NQO1 | SIGMAR1 2219/4885BCHE 170/4885LTA4H 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.